SB 203580

SB 203580^[1]
Names
	Preferred IUPAC name 4-{4-(4-Fluorophenyl)-2-[4-(methanesulfinyl)phenyl]-1H-imidazol-5-yl}pyridine
	Other names RWJ-64809;
Identifiers
CAS Number	152121-47-6 ;
3D model (JSmol)	Interactive image;
ChEBI	CHEBI:90705;
ChEMBL	ChEMBL10 ;
ChemSpider	153453 ;
ECHA InfoCard	100.214.849
EC Number	688-252-3;
IUPHAR/BPS	5269;
PubChem CID	176155;
UNII	OU13V1EYWQ ;
CompTox Dashboard (EPA)	DTXSID2040577 ;
	InChI InChI=1S/C21H16FN3OS/c1-27(26)18-8-4-16(5-9-18)21-24-19(14-2-6-17(22)7-3-14)20(25-21)15-10-12-23-13-11-15/h2-13H,1H3,(H,24,25) Key: CDMGBJANTYXAIV-UHFFFAOYSA-N ; InChI=1/C21H16FN3OS/c1-27(26)18-8-4-16(5-9-18)21-24-19(14-2-6-17(22)7-3-14)20(25-21)15-10-12-23-13-11-15/h2-13H,1H3,(H,24,25) Key: CDMGBJANTYXAIV-UHFFFAOYAY;
	SMILES CS(=O)C1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F;
Properties
Chemical formula	C21H16FN3OS
Molar mass	377.43 g/mol
Appearance	White to off-white solid
Solubility in DMSO	50 mg/mL
Hazards
	GHS labelling:
Pictograms
Signal word	Danger
Hazard statements	H302, H318
Precautionary statements	P264, P270, P280, P301+P312, P305+P351+P338, P310, P330, P501
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

SB 203580 is a specific inhibitor of p38α and p38β which suppresses downstream activation of MAPKAP kinase-2 and heat shock protein 27. At low concentrations, it does not inhibit JNK activity. SB-203580 was recently assigned the INN Adezamapimod, and is currently in phase 2 clinical trials to prevent post-operative tissue adhesion.

References

^ SB 203580 at Sigma-Aldrich

This article about an organic compound is a stub. You can help Wikipedia by expanding it.

[1] SB 203580 at Sigma-Aldrich

[1]